Starpharma Holdings Limited [ASX:SPL] share price and news 2022

Company Description

Starpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL’s underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses. SPL has two core development programs: VivaGel portfolio and DEP drug delivery. As of now Company is focused on development of VIRALEZE nasal spray.

Starpharma Holdings Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.starpharma.com.

This a small cap company with market cap of 761 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is greater than both sector and market.

Earnings PE PB PE growth
Company 3 0 22.3 0
Market 1.03 20.6 1.71 1.15
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how spl dividend grows in the recent years.

No data